Personalizing induction therapy in kidney transplantation Article uri icon

Overview

MeSH Major

  • Antilymphocyte Serum
  • Graft Rejection
  • Immunosuppressive Agents
  • Kidney Transplantation
  • Precision Medicine

abstract

  • Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.

publication date

  • November 2009

Research

keywords

  • Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/nrneph.2009.164

PubMed ID

  • 19855425

Additional Document Info

start page

  • 619

end page

  • 20

volume

  • 5

number

  • 11